We are live on ! Find out more
TVTX icon

Travere Therapeutics

148 hedge funds and large institutions have $1.48B invested in Travere Therapeutics in 2021 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 43 increasing their positions, 53 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

9% more funds holding

Funds holding: 136148 (+12)

1.07% less ownership

Funds ownership: 101.35%100.28% (-1.1%)

19% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 53

Holders
148
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.19M
Puts
$5.08M
Net Calls
Net Calls Change

Top Sellers

1 -$34.8M
2 -$25.1M
3 -$18.4M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$14.6M
5
Bank of America
Bank of America
North Carolina
-$13.2M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$427K
102
$401K
103
$399K
104
$392K
105
$359K
106
$317K
107
$277K
108
$262K
109
$253K
110
$238K
111
$237K
112
$235K
113
$217K
114
$202K
115
$201K
116
$186K
117
$133K
118
$109K
119
$108K
120
$87K
121
$83K
122
$76K
123
$48K
124
$41K
125
$36K